Home About Chat Users Issues Party Candidates Polling Firms Media News Polls Calendar Key Races United States President Senate House Governors International

New User Account
"A comprehensive, collaborative elections resource." 
Email: Password:

  After meeting with pharma lobbyists, Trump drops promise to negotiate drug prices
NEWS DETAILS
Parent(s) Issue 
ContributorRP 
Last EditedRP  Feb 01, 2017 01:55pm
Logged 0
CategoryGeneral
AuthorMatthew Yglesias
News DateTuesday, January 31, 2017 04:50:00 PM UTC0:0
DescriptionA lot happened in the 2016 campaign, but one of the things Donald Trump did to win the election was shift to the left on a number of key issues — promising to avoid cuts in Social Security and Medicare benefits and adopting a longstanding Democratic pledge to let Medicare negotiate bulk discounts in the price it pays for prescription drugs.

Today, after a meeting with pharmaceutical industry lobbyists and executives, he abandoned that pledge, referring to an idea he supported as recently as three weeks ago as a form of “price fixing” that would hurt “smaller, younger companies.” Instead of getting tough, Trump’s new plan is that he’s “going to be lowering taxes” and “getting rid of regulations.”
Share
ArticleRead Full Article

NEWS
Date Category Headline Article Contributor

DISCUSSION